Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of MA-5 in healthy adult men
jRCT2031210495Phase 1Completed
- Sponsor
- Tohoku University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of MA-5 in Mitochondriopathy (7 cohorts), sponsored by Tohoku University. Primary endpoints: Safety and tolerability and Pharmacokinetics of MA-5. Started Dec 2021; status: completed.
02
Drugs
MA-5
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on jRCT2031210495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210495.